[PCRX] QoQ Quarter Result on 30-Sep-2012 [#Q3]

Stock
[PCRX] Pacira BioSciences, Inc.
Announcement Date
01-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- -89.79%
YoY- -65.60%
Quarter Report
PCRX's Result
PCRX's Financial Summary
View:
Show?
Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 17,141 11,587 10,450 8,486 12,344 7,804 4,233 154.27%
PBT -14,031 -23,580 -16,346 -15,745 -8,296 -11,894 -33,820 -44.40%
Tax 610 -442 -27,639 39 494 757 -18,538 -
NP -14,031 -23,138 -16,346 -15,745 -8,296 -11,894 -15,283 -5.54%
Tax Rate - - - - - - - -
Total Cost 31,172 34,725 26,796 24,231 20,640 19,698 19,516 36.68%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin -81.86 -199.69 -156.42 -185.54 -67.21 -152.41 -361.04 -62.85%
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
EPS -0.42 -0.71 -0.51 -0.49 -0.27 -0.47 -0.60 -21.17%
EPS Diluted -0.42 -0.71 -0.50 -0.49 -0.27 -0.47 -0.60 -21.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.